PRESS RELEASE published on 12/17/2024 at 22:15, 1 year 6 months ago NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024 Nanobiotix announces virtual event 'Accelerating the Future of Nanotherapeutics' on December 19, 2024, showcasing Curadigm Nanoprimer Platform for drug development Virtual Event NANOBIOTIX Curadigm Nanotherapeutics Nanoprimer
BRIEF published on 12/09/2024 at 22:20, 1 year 6 months ago Nanobiotix successfully completes phase 1 study in pancreatic cancer FDA Pancreatic Cancer Chemotherapy Phase 1 Study Radiotherapy
PRESS RELEASE published on 12/09/2024 at 22:15, 1 year 6 months ago NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer Nanobiotix completes Phase 1 study of NBTXR3 in pancreatic cancer, showing promising outcomes & safety profile. FDA approves new trial. Full data to be shared in 2025 FDA Approval Pancreatic Cancer NANOBIOTIX NBTXR3 Phase 1 Study
BRIEF published on 11/25/2024 at 09:53, 1 year 6 months ago Threshold Crossing by Baillie Gifford at Nanobiotix Voting Rights Capital Threshold Crossing NANOBIOTIX Baillie Gifford
BRIEF published on 10/31/2024 at 08:35, 1 year 7 months ago NANOBIOTIX to Participate in Investor Conferences in November Innovation Investors Healthcare Conférences NANOBIOTIX
PRESS RELEASE published on 10/31/2024 at 08:30, 1 year 7 months ago NANOBIOTIX to Participate in Multiple Investor Conferences in November Nanobiotix to participate in multiple investor conferences in November, including Guggenheim, Stifel, and Jefferies events to discuss innovative healthcare approaches Investor Conferences Healthcare Innovation NANOBIOTIX Nanoparticle-based Approaches Late-stage Biotechnology
BRIEF published on 10/11/2024 at 22:20, 1 year 8 months ago Voting Rights and Share Capital Update by Nanobiotix Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
PRESS RELEASE published on 10/11/2024 at 22:15, 1 year 8 months ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital information. Find out more about the company's innovative therapeutic approaches Voting Rights Biotechnology Shares Capital NANOBIOTIX Therapeutic Approaches
BRIEF published on 09/18/2024 at 22:20, 1 year 8 months ago NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results Revenue Increase Clinical Milestones Nanobiotix Financials NBTXR3 Progress Cash And Runway
PRESS RELEASE published on 09/18/2024 at 22:15, 1 year 8 months ago NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results Nanobiotix updates on operational progress and reports Half Year 2024 financial results, showcasing clinical milestones and licensing agreements with Janssen. Cash reserves extended until Q4 2025 Financial Results Clinical Milestones NANOBIOTIX Half Year 2024 Janssen Agreement
Published on 06/18/2026 at 00:00, 6 hours 48 minutes ago LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 7 hours 18 minutes ago Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 7 hours 58 minutes ago International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 8 hours 18 minutes ago Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 13 hours 53 minutes ago Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/18/2026 at 06:30, 17 minutes ago Schindler Holding Ltd. increases ongoing share buyback program to up to CHF 700 million
Published on 06/18/2026 at 04:05, 2 hours 42 minutes ago Hisense Brings Smarter Home Experiences to Families During the FIFA World Cup 2026™
Published on 06/18/2026 at 02:45, 4 hours 3 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Update on APAC matter
Published on 06/17/2026 at 21:40, 9 hours 7 minutes ago Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
Published on 06/17/2026 at 19:10, 11 hours 38 minutes ago Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 17:40, 13 hours 8 minutes ago Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 22 hours 3 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 19 hours ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days 7 hours ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 11 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026
